Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Paoletti

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
Vaccines|May 27, 2023
The Prevalence of Immediate Hypersensitivity Reactions to the BNT162b2 mRNA Vaccine against SARS-CoV-2: Data from the Vaccination Campaign in a Large Academic HospitalGiovanni Paoletti, Jack Pepys, Maria Chiara Bragato, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 5, 2024
Asthma management, focused on the use of oral corticosteroids: the opinions of Italian asthmatic patientsManuela Latorre, Angela Rizzi, Pierluigi Paggiaro, et al.
Allergy|March 6, 2021
Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?Enrico Heffler, Aikaterini Detoraki, Marco Contoli, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|September 13, 2025
Real-world evidence in pediatricsMattia Giovannini, Francesco Catamerò, Ioana Agache, et al.
Allergy|August 2, 2020
COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatmentsEnrico Heffler, Aikaterini Detoraki, Marco Contoli, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 31, 2023
Sleep quality burden in chronic rhinosinusitis with nasal polyps and its modulation by dupilumabSebastian Ferri, Carlo Montagna, Marta Casini, et al.
Pulmonary Pharmacology & Therapeutics|September 2, 2019
One year of mepolizumab. Efficacy and safety in real-life in ItalyDiego Bagnasco, Marco Caminati, Francesco Menzella, et al.
The World Allergy Organization Journal|November 2, 2022
Nasal cytology as a reliable non-invasive procedure to phenotype patients with type 2 chronic rhinosinusitis with nasal polypsGiovanni Paoletti, Luca Malvezzi, Anna Maria Riccio, et al.
Frontiers in Allergy|December 31, 2025
Chronic rhinosinusitis with and without nasal polyps: the state-of-the-art of current treatment strategies and future developmentsEmanuele Nappi, Valentina Marzio, Francesco Giombi, et al.
Allergy|November 28, 2019
The importance of being not significant: Blood eosinophils and clinical responses do not correlate in severe asthma patients treated with mepolizumab in real lifeDiego Bagnasco, Alessandro Massolo, Marco Bonavia, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Vaccines|May 27, 2023
The Prevalence of Immediate Hypersensitivity Reactions to the BNT162b2 mRNA Vaccine against SARS-CoV-2: Data from the Vaccination Campaign in a Large Academic HospitalGiovanni Paoletti, Jack Pepys, Maria Chiara Bragato, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 5, 2024
Asthma management, focused on the use of oral corticosteroids: the opinions of Italian asthmatic patientsManuela Latorre, Angela Rizzi, Pierluigi Paggiaro, et al.
Allergy|March 6, 2021
Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19?Enrico Heffler, Aikaterini Detoraki, Marco Contoli, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|September 13, 2025
Real-world evidence in pediatricsMattia Giovannini, Francesco Catamerò, Ioana Agache, et al.
Allergy|August 2, 2020
COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatmentsEnrico Heffler, Aikaterini Detoraki, Marco Contoli, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 31, 2023
Sleep quality burden in chronic rhinosinusitis with nasal polyps and its modulation by dupilumabSebastian Ferri, Carlo Montagna, Marta Casini, et al.
Pulmonary Pharmacology & Therapeutics|September 2, 2019
One year of mepolizumab. Efficacy and safety in real-life in ItalyDiego Bagnasco, Marco Caminati, Francesco Menzella, et al.
The World Allergy Organization Journal|November 2, 2022
Nasal cytology as a reliable non-invasive procedure to phenotype patients with type 2 chronic rhinosinusitis with nasal polypsGiovanni Paoletti, Luca Malvezzi, Anna Maria Riccio, et al.
Frontiers in Allergy|December 31, 2025
Chronic rhinosinusitis with and without nasal polyps: the state-of-the-art of current treatment strategies and future developmentsEmanuele Nappi, Valentina Marzio, Francesco Giombi, et al.
Allergy|November 28, 2019
The importance of being not significant: Blood eosinophils and clinical responses do not correlate in severe asthma patients treated with mepolizumab in real lifeDiego Bagnasco, Alessandro Massolo, Marco Bonavia, et al.
Pageof 13